Contact CFFC


Clinical Trial Alerts – December 2017

Cystic Fibrosis Foundation distributed the following clinical trial updates during the month of December. Click the trial title to get more details.

The following alert was issued on December 1, 2017:

Sweat chloride observational study

Status: Enrolling

Description: This study is taking place at multiple care centers across the U.S. It will look at sweat chloride concentration in people who are currently taking CFTR modulators.

Age: 4 Months and Older

Mutation: No Mutation Requirement

Fev1% Predicted: No FEV1 Limit

Number of Visits: 1

Length of Participation: 1 days

ClinicaTrial,gov link:

Comments are closed.